Resistencia de HIV-1 a drogas antirretrovirales en gestantes del área metropolitana de Buenos Aires

Zapiola, Inés; Cecchini, Diego; Fernández Giuliano, Silvina; Martínez, Marina; Rodríguez, Claudia; Bouzas, Maria Belén.
Medicina (B.Aires) ; 76(6): 349-354, dic. 2016. tab
Artigo em Espanhol | LILACS | ID: biblio-841608

Documentos relacionados

  1. [HIV-1 resistance to antiretroviral drugs in pregnant women from Buenos Aires metropolitan area].
  2. An observational study of high- and low-abundance anti-retroviral resistance mutations among treatment-naïve people living with HIV in New Zealand between 2012 and 2017.
  3. Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Hungary.
  4. Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries.
  5. Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018.
  6. Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.
  7. The prevalence of HIV resistance mutations and their influence on the shedding of HIV-1 into peritoneal dialysis effluent.
  8. High prevalence of HIV-1 transmitted drug resistance and factors associated with time to virological failure and viral suppression in Taiwan.
  9. Prevalence of HIV-1 Drug Resistance among Patients with Antiretroviral Therapy Failure in Sichuan, China, 2010-2016.
  10. Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.